Volume 78, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Martinique experienced a dengue outbreak with co-circulation of DENV-2 and DENV-4. In an emergency department-based study, we analyzed whether the clinical presentation and outcome of adult patients were related to serotype, immune status, or plasma viral load. Of the 146 adult patients who had confirmed dengue infection, 91 (62.3%) were classified as having classic dengue fever, 11 (7.5%) fulfilled World Health Organization criteria for dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), 21 other patients (14.4%) presented with at least one typical feature of DHF/DSS [i.e., internal hemorrhage, plasma leakage, marked thrombocytopenia (platelet count ≤ 50,000 platelets/mm) and/or shock], and 23 further patients (15.8%) had unusual manifestations. Four patients died. Severe illness was more frequent in patients with secondary dengue infection (odds ratio, 7.18; 95% confidence interval, 3.1–16.7; < 0.001). Multivariate regression analysis showed that gastrointestinal symptoms and other unusual manifestations were independently associated with DENV-2 infection, whereas cough and DHF/DSS features were independently associated with secondary immune response. A high plasma viral load was associated with DENV-2 infection, increased serum liver enzymes, and with DHF/DSS features in patients presenting after the third day of illness. The most severe cases of dengue resulted from the combined effects of DENV-2 and secondary infection.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Second edition. Geneva: World Health Organization.
  2. Halstead SB, 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239 : 476–481. [Google Scholar]
  3. Gubler DJ, 1998. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11 : 480–496. [Google Scholar]
  4. Rothman A, 2003. Immunology and immunopathogenesis of dengue disease. Adv Virus Res 60 : 397–419. [Google Scholar]
  5. Guzman MG, Kouri G, 2002. Dengue: an update. Lancet Infect Dis 2 : 33–42. [Google Scholar]
  6. Guzman MG, Kouri G, 2003. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 27 : 1–13. [Google Scholar]
  7. Anonymous, 2006. Situation épidémiologique de la dengue dans les Antilles Françaises. Bulletins d’Alertes et de Surveillance Antilles Guyane. Available at: http://www.martinique.sante.gouv.fr/documents/accueil/cire/basag2006-7.pdf. Accessed 7 November 2007.
  8. Dussart P, Lavergne A, Lagathu G, Lacoste V, Martial J, Morvan J, Cesaire R, 2006. Reemergence of dengue virus type 4, French Antilles and French Guiana, 2004–2005. Emerg Infect Dis 12 : 1748–1751. [Google Scholar]
  9. Tolou H, Coussinier-Paris P, Mercier V, Pisano MR, de Lamballeie X, de Micco P, Durand J-P, 2000. Complete genomic sequence of a dengue type 2 virus from the French West Indies. Biochem Biophys Res Commun 277 : 89–92. [Google Scholar]
  10. Rigau-Perez JG, 2006. Severe dengue: the need for new case definitions. Lancet Infect Dis 6 : 297–302. [Google Scholar]
  11. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, Dung NM, Hung NT, Hien TT, Farrar JJ, 2006. The WHO dengue classification and case definitions: time for a reassessment. Lancet 368 : 170–173. [Google Scholar]
  12. Phuong CXT, Nhan NT, Kneen R, Thuy PT, van Thien C, Nga NT, Thuy TT, Solomon T, Stepniewska K, Wills B, and the Dong Nai Study Group 2004. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the World Health Organization classification system helpful? Am J Trop Med Hyg 70 : 172–179. [Google Scholar]
  13. Hammond SN, Balmaseda A, Pérez L, Tellez Y, Saborío SI, Mercado JC, Videa E, Rodriguez Y, Pérez MA, Cuadra R, Solano S, Rocha J, Idiaquez W, Gonzalez A, Harris E, 2005. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg 73 : 1063–1070. [Google Scholar]
  14. Balmaseda A, Hammond SN, Perez MA, Cuadra R, Solano S, Rocha J, Idiaquez W, Harris E, 2005. Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg 73 : 1059–1062. [Google Scholar]
  15. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV, 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30 : 545–551. [Google Scholar]
  16. Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Keen R, Cuzzubbo A, Devine PL, 1999. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary dengue infection. Am J Trop Med Hyg 60 : 693–698. [Google Scholar]
  17. Vazquez S, Hafner G, Ruiz D, Calzada N, Guzman MG, 2007. Evaluation of immunoglobulin M and G capture enzyme-linked immunosorbent assay Panbio kits for diagnostic dengue infections. J Clin Virol 39 : 194–198. [Google Scholar]
  18. Carrington CV, Foster JE, Pybus OG, Bennett SN, Holmes EC, 2005. Invasion and maintenance of dengue virus type 2 and type 4 in the Americas. J Virol 79 : 14680–14687. [Google Scholar]
  19. Guzmán MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, Delgado I, Halstead SB, 2000. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am J Epidemiol 152 : 793–799. [Google Scholar]
  20. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakom U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW, 2003. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68 : 191–202. [Google Scholar]
  21. Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjørup I, Lopez-Velez R, Clerinx J, Peyerl-Hoffmann G, Sundøy A, Genton B, Kern P, Calleri G, de Gorgolas M, Mühlberger N, Jelinek T for the European Network on Surveillance of Imported Infectious Diseases, 2007. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis 195 : 1089–1095. [Google Scholar]
  22. Davis JS, Bourke P, 2004. Rhabdomyolysis associated with dengue virus infection. Clin Infect Dis 38 : e109–e111. [Google Scholar]
  23. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakom S, Kunentrasai N, Viramitrachai W, Ratanachu-eke S, Kiatpolpoj S, Innis BL, Rothman AL, Nisalak A, Ennis FA, 1997. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 176 : 313–321. [Google Scholar]
  24. Murgue B, Deparis X, Chungue E, Cassar O, Roche C, 1999. Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases. Trop Med Int Health 4 : 765–773. [Google Scholar]
  25. Ling LM, Wilder-Smith A, Leo YS, 2007. Fulminant hepatitis in dengue haemorrhagic fever. J Clin Virol 38 : 265–268. [Google Scholar]
  26. Krishnamurti C, Kalayanarooj S, Cutting MA, Peat RA, Rothwell SW, Reid TJ, Green S, Nisalak A, Endy TP, Vaughn DW, Nimmannitya S, Innis BL, 2001. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 65 : 840–847. [Google Scholar]
  27. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L, 1990. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 42 : 179–184. [Google Scholar]
  28. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A, 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181 : 2–9. [Google Scholar]
  29. Kuberski T, Rosen L, Reed D, Mataika J, 1977. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. Am J Trop Med Hyg 26 : 775–783. [Google Scholar]
  30. Murgue B, Roche C, Chungue E, Deparis X, 2000. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996–1997 dengue-2 outbreak in French Polynesia. J Med Virol 60 : 432–438. [Google Scholar]
  31. Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, Yang KD, 2006. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol Med Microbiol 48 : 84–90. [Google Scholar]
  32. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL, 2002. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185 : 1213–1221. [Google Scholar]
  33. Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC, Chang SM, Yu CC, Lin LH, Huang JH, King CC, 2006. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 43 : 1023–1030. [Google Scholar]
  34. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanowathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G, 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9 : 921–927. [Google Scholar]
  35. Screaton G, Mongkolsapaya J, 2006. T cell responses and dengue haemorrhagic fever. Novartis Found Symp 277 : 164–171. [Google Scholar]
  36. Green S, Rothman A, 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19 : 429–436. [Google Scholar]
  37. Burke DS, Kliks S, 2006. Antibody-dependent enhancement in dengue virus infections. J Infect Dis 193 : 601–603. [Google Scholar]
  38. Cabie A, Strobel M, 2003. The clinical expression of dengue. Corriveau R, Philippon B, Yebakima A, eds. Dengue in Martinique, Guadeloupe and French Guiana. Paris: IRD Editions, 167–171.
  39. Halstead SB, 2006. Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica 20 : 407–415. [Google Scholar]
  40. Sierra BL, Kouri G, Guzman MG, 2007. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152 : 533–542. [Google Scholar]
  41. Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, Kanesa-Thasan N, Hayes CG, Watts DM, 2001. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg 65 : 180–183. [Google Scholar]

Data & Media loading...

  • Received : 14 Dec 2007
  • Accepted : 06 Mar 2008

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error